Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC
Clinical trial NCT06829641 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06829641
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-09
- Primary completion
- 2025-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.